33 results
8-K
EX-99.2
VIR
Vir Biotechnology Inc
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
, reputational harm and the curtailment or restructuring of our operations.
If the physicians or other providers or entities with whom we expect to do … contracting with certain persons, the loss of export privileges, reputational harm, adverse media coverage and other collateral consequences. If any
S-1
EX-10.5
mcce6
3 Sep 19
IPO registration
4:40pm
DRS
EX-10.5
hnkg t0gjc3g
27 Jun 19
Draft registration statement
12:00am
10-Q
dzbqcic5q
19 Nov 19
Quarterly report
4:06pm
10-K
5x0ym4 pu
26 Mar 20
Annual report
4:08pm